160 results

• More Than a Third of GLP-1 Drug Users Microdose To Avoid Side Effects, Survey Finds

  May 2, 2025

  Irvin Jackson

  Most users of Ozempic and similar drugs say they currently take microdoses of the medications or have done so in the past.

• Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks

  March 21, 2025

  Irvin Jackson

  Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs.

• GLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing

  March 17, 2025

  Irvin Jackson

  Eli Lilly has filed a motion calling for a federal judge to put in place specific requirements for establishing a gastroparesis diagnosis in stomach paralysis lawsuits filed against the makers of Mounjaro, Ozempic and other GLP-1 medications.

• Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia

  March 12, 2025

  Irvin Jackson

  New findings appear to contradict warnings that GLP-1 drugs, like Ozempic and Mounjaro, can increase the risk of post-surgical aspiration due to a lack of gastric emptying.

• Stomach Paralysis Lawsuit Filed Over Side Effects of Ozempic, Trulicity, Rybelsus

  February 26, 2025

  Irvin Jackson

  A lawsuit claims the side effects of Ozempic, Trulicity and Rybelsus caused a woman to develop severe stomach paralysis, which led to the need for medical treatment.

• Victoza Caused Side Effects in 80% of Children, But Helped Them Lose Weight: Study

  February 12, 2025

  Irvin Jackson

  Most children given Victoza for about a year suffered gastrointestinal adverse events, according to a study that also concludes the drug could help some obese children significantly reduce their BMI.

• GLP-1 Drug Prescriptions Have Doubled in Recent Years, But Many Users Quit Soon After Starting

  February 10, 2025

  Irvin Jackson

  Two new studies mark the rapid rise in Ozempic, Wegovy, Zepbound and other GLP-1 medication prescriptions in recent years, but warns that a variety of factors, including side effects, age, income and weight loss, often make new users quit within a year.

• GLP-1 Lawsuit Defendants Filed Motion To Dismiss Most Claims in Plaintiffs’ Master Complaint

  January 31, 2025

  Irvin Jackson

  Two major drug manufacturers are asking a federal judge to dismiss most claims presented in GLP-1 lawsuits, which allege that side effects of Ozempic, Mounjaro and similar drugs cause severe gastrointestinal side effects.

• Increased GLP-1 Thyroid Cancer Risks May Be Product of More Intense Screening, Study Finds

  January 29, 2025

  Irvin Jackson

  The findings of a new study suggest that an apparent association between GLP-1 medications and thyroid cancer may be due to more intensive patient screening, and not a side effect of the drugs themselves.

• Side Effects of Ozempic, Other GLP-1 Drugs Are Mixed, With Net Benefits Overall: Study

  January 22, 2025

  Irvin Jackson

  A new study attempts to categorize the benefits and risks of drugs like Ozempic and Mounjaro, finding that they decrease the risk of many metabolic health problems due to the weight lost, while warning of potential gastrointestinal problems such as stomach paralysis, and an increased risk of acute pancreatitis.